Hawk Ridge Capital Management LP Takes $35.76 Million Position in The Cooper Companies, Inc. $COO

by · The Markets Daily

Hawk Ridge Capital Management LP acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 423,900 shares of the medical device company’s stock, valued at approximately $35,756,000. Cooper Companies accounts for 1.7% of Hawk Ridge Capital Management LP’s investment portfolio, making the stock its 23rd largest position. Hawk Ridge Capital Management LP owned about 0.21% of Cooper Companies at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. raised its position in Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock valued at $2,194,000 after buying an additional 3,440 shares during the period. DAVENPORT & Co LLC increased its holdings in shares of Cooper Companies by 13.4% in the 1st quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company’s stock valued at $366,000 after purchasing an additional 513 shares during the period. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 6.6% in the 1st quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company’s stock valued at $1,443,000 after purchasing an additional 1,054 shares during the period. State of Alaska Department of Revenue boosted its holdings in shares of Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company’s stock worth $1,972,000 after purchasing an additional 680 shares during the period. Finally, Cetera Investment Advisers grew its position in Cooper Companies by 1.3% during the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company’s stock valued at $2,211,000 after purchasing an additional 312 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on COO shares. Piper Sandler cut their target price on shares of Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a research report on Thursday, August 28th. Stifel Nicolaus reduced their price objective on Cooper Companies from $90.00 to $85.00 and set a “buy” rating for the company in a research report on Thursday, August 28th. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, August 28th. Loop Capital set a $100.00 price target on Cooper Companies in a research note on Tuesday, June 17th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $94.00 price target on shares of Cooper Companies in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $86.64.

View Our Latest Report on Cooper Companies

Cooper Companies Stock Up 2.8%

COO opened at $67.14 on Thursday. The firm has a market cap of $13.35 billion, a P/E ratio of 33.07, a price-to-earnings-growth ratio of 1.63 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.23 and a current ratio of 2.12. The business has a 50 day moving average price of $72.09 and a 200 day moving average price of $76.99. The Cooper Companies, Inc. has a twelve month low of $61.78 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. Cooper Companies’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Activity

In other Cooper Companies news, COO Daniel G. Mcbride bought 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was purchased at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the purchase, the chief operating officer directly owned 63,120 shares in the company, valued at $4,105,324.80. This trade represents a 4.99% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian G. Andrews bought 1,525 shares of the stock in a transaction on Tuesday, September 2nd. The stock was acquired at an average cost of $65.68 per share, for a total transaction of $100,162.00. Following the acquisition, the executive vice president directly owned 22,191 shares in the company, valued at approximately $1,457,504.88. The trade was a 7.38% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.98% of the company’s stock.

About Cooper Companies

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

See Also

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).